» Articles » PMID: 38381210

Intratumoral Heterogeneity, Chemoresistance and Lymph Node Landing Zone Prognosis in Testicular Tumors Based on Histopathological Characteristics

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2024 Feb 21
PMID 38381210
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Existing data on the histopathological correlation of testicular tumors with lymph node prognosis have been poorly explored. We aimed to investigate the relationship of the histopathological properties of testicular tumors with lymph nodes and their involvement with chemoresistance and heterogeneity of testicular tumors.

Methods: Patients with non-seminomatous germ cell tumor (NSGCT) were selected for histopathological correlation of testicular tumor with lymph nodes and its relationship with chemoresistance and heterogeneity. Histopathological and radiological parameters associated with the risk of chemoresistance and tumor progression were measured pre- and post-chemotherapy. Binomial logistic regression and Kaplan-Meier analysis were implemented to determine the predictors of progression and adverse overall patient survival. All categorical variables were analyzed using the Chi-square test, while Pearson's R coefficient determined the correlation.

Results: Male patients who were diagnosed with NSGCT from March 2017 to December 2018 at Guwahati Medical College, Guwahati, India, were included in this study. Lymph node groups were predominantly incriminated with the EYST or EYS groups and minimally linked with the pure E and YCS groups. Furthermore, the highest number of lymph node stations was associated with pre-chemotherapy. In salvage chemotherapy in the form of VIP, we found exciting outcomes, as approximately 41% of cases responded positively, especially in the EYS group.

Conclusion: Our study classifies NSGCT according to the most favorable histopathological grouping and explores the tumoral response in different intrinsic and extrinsic variables. Our analysis can serve as a triumphant histopathological nomogram for a sublime management protocol to deal with the onerous histological pairing in NSGCT.

References
1.
Baroni T, Arato I, Mancuso F, Calafiore R, Luca G . On the Origin of Testicular Germ Cell Tumors: From Gonocytes to Testicular Cancer. Front Endocrinol (Lausanne). 2019; 10:343. PMC: 6563414. DOI: 10.3389/fendo.2019.00343. View

2.
Monteiro-Reis S, Lobo J, Henrique R, Jeronimo C . Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer. Int J Mol Sci. 2019; 20(2). PMC: 6358899. DOI: 10.3390/ijms20020297. View

3.
Greenlee R, Murray T, Bolden S, Wingo P . Cancer statistics, 2000. CA Cancer J Clin. 2000; 50(1):7-33. DOI: 10.3322/canjclin.50.1.7. View

4.
Winter C, Zengerling F, Busch J, Heinzelbecker J, Pfister D, Ruf C . How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence. World J Urol. 2022; 40(12):2863-2878. PMC: 9712285. DOI: 10.1007/s00345-022-04009-z. View

5.
Tongaonkar H . Testicular cancer: current management and controversial issues. Indian J Urol. 2010; 26(1):63. PMC: 2878441. DOI: 10.4103/0970-1591.60447. View